Patents by Inventor Eun Jung Lim
Eun Jung Lim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210058359Abstract: A method of displaying an interface for providing a social networking service (SNS) through an anonymous profile, performed by a user terminal, includes displaying a first list of at least one anonymous chatroom created by a user account for an instant messaging service (IMS) using a first region on a first page in an interface for the IMS, displaying a second list of at least one anonymous profile created to be interlinked with the user account using a first region on a second page in the interface for the IMS, and displaying, in response to an input of selecting any one anonymous profile in the second list, an interface for providing the SNS to through the selected anonymous profile.Type: ApplicationFiled: August 21, 2020Publication date: February 25, 2021Inventors: Ji Sun LEE, Hyun Young PARK, Seong Mi LIM, Young Min PARK, Doo Won LEE, Eun Jung KO, Jae Lin LEE, Kwang Hui LIM, Ki Yong SHIM, Sun Ho CHOI, Kwang Hoon CHOI, Hwa Young LEE, Jae Gil LEE, Kyong Rim KIM, Soo Min CHO
-
Patent number: 10851175Abstract: The present invention relates to an antibody specifically bound to mesothelin (MSLN), a nucleic acid encoding the antibody, a vector and a host cell including the nucleic acid, a method for producing the antibody, and a pharmaceutical composition for treating cancer or tumor including the antibody as an active ingredient. The antibody specifically bound to the mesothelin according to the present invention has high affinity and specificity to an antigen, such that it is possible to develop an antibody effectively usable for treatment or diagnosis of cancer or tumor diseases.Type: GrantFiled: September 23, 2016Date of Patent: December 1, 2020Assignees: MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH, GREEN CROSS CORPORATIONInventors: Dong-Sik Kim, Eun Jung Song, Mijung Lee, Eun-Hee Lee, Miyoung Oh, Jae Chan Park, Kisu Kim, Sujeong Kim, Hyung-Kwon Lim, Kyuhyun Lee, Jongwha Won, Soongyu Choi, Young Seoub Park
-
Publication number: 20200348556Abstract: The present application relates to a light modulation device and a use thereof. The present application can provide a light modulation device having both excellent mechanical properties and optical properties by applying a polymer film that is also optically anisotropic and mechanically anisotropic to a substrate.Type: ApplicationFiled: July 16, 2020Publication date: November 5, 2020Applicant: LG Chem, Ltd.Inventors: Hyun Jun Lee, Eun Jung Lim, Jung Sun You, Min Jun Gim, Dong Hyun Oh, Jin Hong Kim
-
Patent number: 10809263Abstract: Provided are an autoantibody specifically binding to an exosomal protein EIF3A (Eukaryotic translation initiation factor 3 subunit A) or a fragment including an antigen-binding site (paratope) thereof, a hybridoma cell line producing the autoantibody, a polypeptide having an amino acid sequence of an antigenic determinant (epitope) specifically binding to the autoantibody, a composition for diagnosing liver cancer including an agent measuring an expression level of the autoantibody or the fragment including the antigen-binding site thereof, a kit for diagnosing liver cancer including the composition, and a method of providing information for diagnosis of liver cancer by using the composition. Further, provided is a method of screening for a therapeutic agent for liver cancer by using an expression level of the autoantibody.Type: GrantFiled: July 8, 2016Date of Patent: October 20, 2020Assignees: PROTEOMETECH INC., KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGYInventors: Eun Wie Cho, Chang Kyu Heo, Hai Min Hwang, Jeong Heon Ko, Kook Jin Lim, Hye Jung Lee
-
Publication number: 20200317779Abstract: The present invention relates to an anti-CD3 antibody and a pharmaceutical composition for cancer treatment comprising same. The antibody according to the present invention has high affinity and specificity for CD3 and thus can be effectively used in cancer prevention or treatment.Type: ApplicationFiled: October 22, 2018Publication date: October 8, 2020Applicants: GREEN CROSS CORPORATIO, MOGAM INSTITUTE FOR BIOMEDICAL RESEARCHInventors: Ki Su KIM, Jun Hong JEONG, Ae Rin YOON, Eun Jung SONG, Hye Ji CHOI, Ok Jae LIM, Yun Jung LEE, Hyung Kwon LIM, Jong Wha WON
-
Publication number: 20200319494Abstract: The present application relates to a light modulating device and an eyewear. The present application can provide a light modulation device having both excellent mechanical properties and optical properties by applying a polymer film that is also optically anisotropic and mechanically anisotropic to a substrate.Type: ApplicationFiled: April 30, 2018Publication date: October 8, 2020Applicant: LG Chem, Ltd.Inventors: Eun Jung Lim, Nam Hun Kim, Jung Sun You, Jin Hong Kim, Hyun Jun Lee, Min Jun Gim, Kyung Ki Hong, In Ju Mun, Dong Hyun Oh
-
Patent number: 10768461Abstract: The present application relates to a light modulation device and a use thereof. The present application can provide a light modulation device having both excellent mechanical properties and optical properties by applying a polymer film that is also optically anisotropic and mechanically anisotropic to a substrate.Type: GrantFiled: April 30, 2018Date of Patent: September 8, 2020Assignee: LG Chem, Ltd.Inventors: Hyun Jun Lee, Eun Jung Lim, Jung Sun You, Min Jun Gim, Dong Hyun Oh, Jin Hong Kim
-
Patent number: 10752697Abstract: The present invention relates to an antibody specifically binding to glypican 3 (GPC3), a nucleic acid encoding the antibody, a vector and a host cell containing the nucleic acid, a method of preparing the antibody, and a pharmaceutical composition for treating cancer or tumor, containing the antibody as an active ingredient. The antibody specifically binding to glypican 3 according to the present invention may be effectively used to treat cancer or tumor, particularly, hepatocellular carcinoma due to high affinity and specificity to glypican 3.Type: GrantFiled: October 27, 2016Date of Patent: August 25, 2020Assignee: MOGAM INSTITUTE FOR BIOMEDICAL RESEARCHInventors: Jae Chan Park, Kisu Kim, Mijung Lee, Eun-Hee Lee, Dong-Sik Kim, Eun Jung Song, Sujeong Kim, Hyung-Kwon Lim, Kyuhyun Lee, Jongwha Won, Soongyu Choi, Young Seoub Park
-
Publication number: 20200233246Abstract: A transmittance-variable device is disclosed herein. In some embodiments, a transmittance-variable device includes first and second guest host layers, the first and second guest host layers are superposed, wherein each of the first and second guest host layers comprise a liquid crystal host and a dichroic dye guest, and wherein the device is capable of switching between a transparent mode and a black mode. The transmittance-variable device can exhibit high transmittance in the transparent state and a high shielding rate in the black state, and can exhibit a high contrast ratio even at the inclination angle, and exhibit excellent viewing angle symmetry in all directions. Such a transmittance-variable device can be applied to various applications including various architectural or automotive materials which need to adjust the transmittance, or eyewear such as goggles for augmented reality experience or sports, sunglasses or helmets.Type: ApplicationFiled: October 30, 2018Publication date: July 23, 2020Applicant: LG Chem, Ltd.Inventors: Eun Jung Lim, Sergey Belyaev, Dong Hyun Oh, Jung Sun You, Jin Hong Kim, Hyun Jun Lee, Min Jun Gim
-
Publication number: 20200225393Abstract: A reflectance-variable mirror using a liquid crystal cell is disclosed herein. In an embodiment, the reflectance-variable mirror may comprise a first liquid crystal cell including a guest host liquid crystal layer, a first reflective polarizing film, a second liquid crystal cell including a retardation-variable liquid crystal layer, a second reflective polarizing film and an absorbing plate sequentially. The reflectance-variable mirror can realize excellent reflectance-variable characteristics by lowering the reflectance in an antireflection mode.Type: ApplicationFiled: December 22, 2017Publication date: July 16, 2020Applicant: LG Chem, Ltd.Inventors: Eun Jung Lim, Jin Hong Kim, Dong Hyun Oh, Jung Sun You, Hyun Jun Lee, Nam Hun Kim
-
Publication number: 20200201094Abstract: The present application relates to an optical element, a driving method of the optical element, a transmittance-variable device and a use thereof. In one example, the present application may provide a driving method suppressing a back-flow phenomenon caused by a bulk liquid crystal compound even when a cell gap of a liquid crystal layer becomes thick. The driving method may ensure excellent response speeds and driving characteristics.Type: ApplicationFiled: September 27, 2018Publication date: June 25, 2020Applicant: LG Chem, Ltd.Inventors: Eun Jung Lim, Dong Hyun Oh, Jung Sun You, Jin Hong Kim, Hyun Jun Lee, Nam Hun Kim, Min Jun Gim
-
Patent number: 10663828Abstract: The present application relates to a liquid crystal device. The liquid crystal device of the present application may realize a transparent white state, a transparent black state and a scattering state according to a level of an applied voltage at a fixed frequency. The liquid crystal device may be applied to, for example, a window of a vehicle, a smart window, a window protective film, a display, a light cutoff panel for a display, an active retarder for a 3D image display or a viewing angle controlling film.Type: GrantFiled: March 31, 2016Date of Patent: May 26, 2020Assignee: LG Chem, Ltd.Inventors: Eun Jung Lim, Sung Joon Min, Jung Sun You, Jung Woon Kim, Jin Hong Kim, Dong Hyun Oh
-
Patent number: 10663825Abstract: The present application relates to a liquid crystal device. The liquid crystal device of the present application may realize a transparent white state, a transparent black state and a scattering state according to a frequency and/or level of an applied voltage. The liquid crystal device may be applied to, for example, a window of a vehicle, a smart window, a window protective film, a display, a light cutoff panel for a display, an active retarder for a 3D image display or a viewing angle controlling film.Type: GrantFiled: March 31, 2016Date of Patent: May 26, 2020Assignee: LG Chem, Ltd.Inventors: Eun Jung Lim, Sung Joon Min, Jung Sun You, Jung Woon Kim, Jin Hong Kim, Dong Hyun Oh
-
Patent number: 10667419Abstract: There are provided an electronic component module in which an external terminal is disposed outwardly from a mold part by a plating process and a manufacturing method thereof. The electronic component module includes a substrate, at least one electronic component mounted on the substrate, a mold part sealing the electronic component, and at least one connection conductor having one end bonded to one surface of the substrate and formed in the mold part so as to penetrate through the mold part. The connection conductor is formed to have a form in which horizontal cross-sectional areas of the connection conductor are gradually reduced toward the substrate and includes at least one step.Type: GrantFiled: November 29, 2017Date of Patent: May 26, 2020Assignee: Samsung Electro-Mechanics Co., Ltd.Inventors: Do Jae Yoo, Eun Jung Jo, Jae Hyun Lim
-
Publication number: 20200159061Abstract: A light modulation device is disclosed herein. In some embodiments, a light modulation device includes a first polymer film substrate, a second polymer film substrate, an active liquid crystal layer disposed between the first and second polymer film substrates, a reflective layer, wherein the active liquid crystal layer is capable of switching between a first orientation state and a second orientation state different from the first orientation state upon application of a voltage, each of the polymer film substrates has an in-plane retardation of 4,000 nm or more for light having a wavelength of 550 nm, a ratio of an elongation (E1) in a first direction to an elongation (E2) in a second direction perpendicular to the first direction of 3 or more, and wherein an angle formed by the first directions of the first and second polymer film substrates is in a range of 0 degrees to 10 degrees.Type: ApplicationFiled: April 30, 2018Publication date: May 21, 2020Applicant: LG Chem, Ltd.Inventors: Min Jun Gim, Eun Jung Lim, Jung Sun You, Jin Hong Kim, Dong Hyun Oh, Hyun Jun Lee
-
Publication number: 20200142246Abstract: A light modulation device is disclosed herein. In some embodiments, a light modulation device includes a first polymer film substrate, a second polymer film substrate, an active liquid crystal layer disposed between the first and second polymer film substrates, wherein the active liquid crystal layer is capable of switching between a first orientation state and a second orientation state when a voltage is applied, and a polarizer, wherein each of the first and second polymer film substrates have in-plane retardation of 4,000 nm or more for light having a wavelength of 550 nm, a ratio of an elongation (E1) in a first direction to an elongation (E2) in a second direction perpendicular to the first direction of 3 or more, and wherein an angle formed by the first directions of the first and second polymer film substrates is in a range of 0 degrees to 10 degrees.Type: ApplicationFiled: April 30, 2018Publication date: May 7, 2020Applicant: LG Chem, Ltd.Inventors: Min Jun Gim, Eun Jung Lim, Jung Sun You, Dong Hyun Oh, Hyun Jun Lee, Nam Hun Kim
-
Patent number: 10611797Abstract: A peptide binding to transcription factor CP2c, having an activity of preventing and treating cancer and represented by SEQ ID NO: 1: Asn-Tyr-Pro-Gln-Arg-Pro, and a pharmaceutical composition and a dietary supplement composition for preventing and treating cancer, both of which contain the same as an active ingredient are disclosed. When cancer cells are treated with the peptide and the pharmaceutical composition containing the same, the peptide can specifically bind to CP2c by passing, with very high stability, through the cell membrane and can inhibit the DNA binding ability of CP2c, thereby disturbing CP2c-mediated cancer cell-specific transcriptional activity through the inhibition of CP2c activity. Thus, the peptide and pharmaceutical composition containing the same can be effectively used for specifically treating only cancer cells and can be utilized for cancer prevention and as a dietary supplement additive therefor.Type: GrantFiled: March 29, 2016Date of Patent: April 7, 2020Assignee: IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY)Inventors: Chul Geun Kim, Min Young Kim, Chan Gil Kim, Ho Chul Kang, Ji Hyung Chae, Su Jae Lee, Eun Jung Baek, Chae Ok Yun, Jin Won Lee, Young Su Lim, Je Min Choi, Dae Hyun Ha, Hyung Sik Won, Seung Han Son
-
Publication number: 20200096807Abstract: A light modulation device is disclosed herein. In some embodiments, a light modulation device includes a first polymer film substrate, a second polymer film substrate, an active liquid crystal layer disposed between the first and second polymer film substrates, wherein the active liquid crystal layer is capable of switching between a vertical orientation state and a twisting orientation state upon application of a voltage, each of the first and second polymer film substrates has an in-plane retardation of 4,000 nm or more for light having a wavelength of 550 nm, a ratio of an elongation (E1) in a first direction to an elongation (E2) in a second direction perpendicular to the first direction of 3 or more, and wherein an angle formed by the first directions of the first and second polymer film substrates is in a range of 0 degrees to 10 degrees.Type: ApplicationFiled: April 30, 2018Publication date: March 26, 2020Applicant: LG Chem, Ltd.Inventors: Min Jun Gim, Eun Jung Lim, Jung Sun You, Hyun Jun Lee, In Ju Mun, Dong Hyun Oh, Nam Gyu Kim, Jin Hong Kim, Hyo Jin Lee, Nam Hun Kim
-
Publication number: 20200050045Abstract: A transmittance-variable device is disclosed herein. In some embodiments, the transmittance-variable device includes a first guest host layer, a second guest host layer, and a phase difference element disposed between the first and second guest host layers, wherein each of the first and second guest host layers comprise a liquid crystal host and a dichroic dye guest, and the liquid crystal hosts are capable of being horizontally oriented such that their optical axes are horizontal to each other. The transmittance-variable device can switch between a clear state and a black state, can exhibit high transmittance in the clear state and a high shielding rate in the black state, and can exhibit a high contrast ratio even at the inclination angle. Such a transmittance-variable device can be used in architectural or automotive materials, or eyewear such as goggles for augmented reality experience or sports, sunglasses or helmets.Type: ApplicationFiled: April 25, 2018Publication date: February 13, 2020Applicant: LG Chem, Ltd.Inventors: Dong Hyun Oh, Eun Jung Lim, Nam Hun Kim
-
Publication number: 20200006443Abstract: Disclosed are a panel capable of performing transparent display, a display device and a vehicle-mounted display device. A transmission part includes an organic light-emitting diode so as to perform light emission as well as display, thereby increasing an emission area, reducing the driving voltage required for emission driving, and consequently increasing the lifespan of the display device.Type: ApplicationFiled: May 14, 2019Publication date: January 2, 2020Inventors: Eun-Jung PARK, Kwan-Soo KIM, Ki-Min LIM